Cardiology

Top Story

TROFI II: Vasomotion more evident with BVS, but issues remain

TROFI II: Vasomotion more evident with BVS, but issues remain
May 24, 2018

Read the Perspective from David J. Moliterno , MD, FACC

In the Journals

Analysis: 2017 ACC/AHA hypertension guideline increases use of antihypertensive treatment

May 24, 2018
More patients were recommended antihypertensive treatment with the 2017 hypertension guidelines compared with the 2014 guidelines, which led to a reduction in all-cause…
In the Journals

Low CV risk profiles may reduce incidence of frailty in older age

May 24, 2018
Adults aged 60 to 69 years with near-ideal CV risk factors have lower incidence of geriatric conditions and frailty, according to recently published data. Researchers…
Meeting News

Hope for renal denervation revived with new sham-controlled trials

May 24, 2018
Two sham-controlled trials demonstrating the efficacy of renal denervation presented at EuroPCR have rekindled hope for the technology as a treatment for hypertension…
FDA News

New iteration of EES receives FDA approval

May 23, 2018
Abbott announced that a new generation of an everolimus-eluting coronary stent system for treatment of patients with complex blockages associated with CAD has received…
More Headlines »